(Q45856064)

English

Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate

scientific article published in March 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

0 references

Coagulation factor VIII

0 references

0 references

author name string

A Gringeri

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

M Monzini

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

G Tagariello

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

F A Scaraggi

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

P M Mannucci

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

Emoclot15 Study Members

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

12

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

128-132

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

The epidemiology of inhibitors in haemophilia A: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Reported inhibitor incidence in FVIII PUP studies: comparing apples with oranges?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Factor VIII inhibitor developed in a 60-year-old patient with mild hemophilia A after surgery for colon cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Inhibitor development in correlation to factor VIII genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01201.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2006.01201.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/16476086

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45856064&oldid=2086711802"